Approaches for estimating minimal clinically important differences in systemic lupus erythematosus

A minimal clinically important difference (MCID) is an important concept used to determine whether a medical intervention improves perceived outcomes in patients. Prior to the introduction of the concept in 1989, studies focused primarily on statistical significance. As most recent clinical trials i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Sharan K, Yazdany, Jinoos, Fortin, Paul R, Aviña-Zubieta, J Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453215/
https://www.ncbi.nlm.nih.gov/pubmed/26036334
http://dx.doi.org/10.1186/s13075-015-0658-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453215/
https://www.ncbi.nlm.nih.gov/pubmed/26036334
http://dx.doi.org/10.1186/s13075-015-0658-6

Ejemplares similares